Biohit, a biotech company based in Finland, has tapped Hefei Medicine to distribute its diagnostic products in China for undisclosed terms. The deal covers products such as the GastroPanel system, a blood-based biomarker assay used to detect Helicobacter pylori.
Biohit strikes Dx supply deal with Hefei Medicine
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|